Analysis of the influence of the T393C polymorphism of the GNAS gene on the clinical expression of primary hyperparathyroidism

Neer, 1995, Proteins: organizers of transmembrane signals, Cell, 80, 249, 10.1016/0092-8674(95)90407-7 Wettschureck, 2005, Proteins and their cell type specific functions, Physiol Rev, 85, 1159, 10.1152/physrev.00003.2005 Lalande, 2001, Imprints of disease at GNAS1, J Clin Invest, 107, 793, 10.1172/JCI12645 De Sanctis, 2003, Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodistrophy and pseudohypoparathyroidism, Pediatr Res, 53, 749, 10.1203/01.PDR.0000059752.07086.A2 Freson, 2002, Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsα deficiency in platelets, Hum Mol Genet, 11, 2741, 10.1093/hmg/11.22.2741 Linglart, 2002, GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistence, J Clin Endocrinol Metab, 87, 189, 10.1210/jcem.87.1.8133 Bastepe, 2001, Paternal uniparental isodisomy of chromosome 20q – and the resulting changes in GNAS1 methylation – as a plausible cause of pseudohypoparathyroidism, Am J Hum Genet, 68, 1283, 10.1086/320117 Mantovani, 2000, Mutational analysis of GNAS1 in patients with pseudohypoparathyroidism: identification of two novel mutations, J Clin Endocrinol Metab, 85, 4243 Frey, 2005, The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer, Cancer Epidemiol Biomarkers Prev, 14, 871, 10.1158/1055-9965.EPI-04-0720 Daaka, 1997, Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A, Nature, 390, 88, 10.1038/36362 Krumins, 1997, Examination of the effects of increasing Gs protein on beta2-adrenergic receptor, Gs, and adenylyl cyclase interactions, Biochem Pharmacol, 54, 61, 10.1016/S0006-2952(97)00147-0 Yang, 1997, Increased expression of Gs(alpha) enhances activation of the adenylyl cyclase signal transduction cascade, Mol Endocrinol, 11, 1053 Frey, 2005, GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer, Clin Cancer Res, 11, 5071, 10.1158/1078-0432.CCR-05-0472 Frey, 2006, The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma, Clin Cancer Res, 12, 759, 10.1158/1078-0432.CCR-05-1722 Lehnerdt, 2008, Overall and relapse-free survival in oro- and hypopharyngeal squamous cell carcinoma are associated with genotypes of the T393C polymorphism of the GNAS1 gene, J Clin Cancer Res, 14, 1753, 10.1158/1078-0432.CCR-07-1605 Moosgaard, 2005, Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism, Clin Endocrinol, 63, 506, 10.1111/j.1365-2265.2005.02371.x Boudou, 2006, A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism, J Endocrinol Invest, 29, 511, 10.1007/BF03344140 Bolland, 2005, Association between primary hyperparathyroidism and increased body weight: a meta-analysis, J Clin Endocrinol Metab, 90, 1525, 10.1210/jc.2004-1891 Vignali, 2009, Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism, J Clin Endocrinol Metab, 94, 2306, 10.1210/jc.2008-2006 Glenn, 2016, Association between body mass index and multigland primary hyperparathyroidism, J Surg Res, 202, 132, 10.1016/j.jss.2015.12.055 Kalla, 2017, Primary hyperparathyroidism predicts hypertension: results from the national inpatient sample, Int J Cardiol, 227, 335, 10.1016/j.ijcard.2016.11.080 Maetani, 2009, Association of leptin, 25-hydroxyvitamin D and parathyroid hormone in women, Nutr Cancer, 61, 225, 10.1080/01635580802455149 Grey, 1994, Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism, Ann Intern Med, 121, 745, 10.7326/0003-4819-121-10-199411150-00003 Oterino, 2007, GNAS1 T393C polymorphism is associated with migraine, Cephalalgia, 27, 429, 10.1111/j.1468-2982.2007.01305.x Uzunoglu, 2013, The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer, Lung Cancer, 79, 151, 10.1016/j.lungcan.2012.11.003 Frey, 2010, GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma, Eur J Med Res, 15, 422, 10.1186/2047-783X-15-10-422 Otterbach, 2007, The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma, Breast Cancer Res Treat, 105, 311, 10.1007/s10549-006-9462-y Vashist, 2011, The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer, Cell Oncol (Dordr), 34, 281, 10.1007/s13402-011-0016-x Schmitz, 2007, GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma, Neoplasia, 9, 159, 10.1593/neo.06796